Literature DB >> 15528623

Users' guide to detecting misleading claims in clinical research reports.

Victor M Montori1, Roman Jaeschke, Holger J Schünemann, Mohit Bhandari, Jan L Brozek, P J Devereaux, Gordon H Guyatt.   

Abstract

Mesh：

Year:  2004        PMID： 15528623      PMCID： PMC526126          DOI： 10.1136/bmj.329.7474.1093

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  14 in total

1.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials.

Authors:  D Moher; K F Schulz; D G Altman
Journal:  Lancet       Date:  2001-04-14       Impact factor: 79.321

2.  The case for structuring the discussion of scientific papers.

Authors:  M Docherty; R Smith
Journal:  BMJ       Date:  1999-05-08

3.  Colloid use for fluid resuscitation: evidence and spin.

Authors:  D Cook; G Guyatt
Journal:  Ann Intern Med       Date:  2001-08-07       Impact factor: 25.391

4.  Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.

Authors:  E J Lewis; L G Hunsicker; W R Clarke; T Berl; M A Pohl; J B Lewis; E Ritz; R C Atkins; R Rohde; I Raz
Journal:  N Engl J Med       Date:  2001-09-20       Impact factor: 91.245

5.  Discussion sections in reports of controlled trials published in general medical journals.

Authors:  Mike Clarke; Phil Alderson; Iain Chalmers
Journal:  JAMA       Date:  2002-06-05       Impact factor: 56.272

6.  Intravascular gamma radiation for in-stent restenosis in saphenous-vein bypass grafts.

Authors:  Ron Waksman; Andrew E Ajani; R Larry White; Rosanna C Chan; Lowell F Satler; Kenneth M Kent; Augusto D Pichard; Ellen E Pinnow; Anh B Bui; Steven Ramee; Paul Teirstein; Joseph Lindsay
Journal:  N Engl J Med       Date:  2002-04-18       Impact factor: 91.245

Review 7.  Scope and impact of financial conflicts of interest in biomedical research: a systematic review.

Authors:  Justin E Bekelman; Yan Li; Cary P Gross
Journal:  JAMA       Date:  2003 Jan 22-29       Impact factor: 56.272

Review 8.  Influences on the quality of published drug studies.

Authors:  L A Bero; D Rennie
Journal:  Int J Technol Assess Health Care       Date:  1996       Impact factor: 2.188

9.  Reviewing the reviewers: the quality of reporting in three secondary journals.

Authors:  P J Devereaux; B J Manns; W A Ghali; H Quan; G H Guyatt
Journal:  CMAJ       Date:  2001-05-29       Impact factor: 8.262

10.  A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.

Authors:  Lindon M H Wing; Christopher M Reid; Philip Ryan; Lawrence J Beilin; Mark A Brown; Garry L R Jennings; Colin I Johnston; John J McNeil; Graham J Macdonald; John E Marley; Trefor O Morgan; Malcolm J West
Journal:  N Engl J Med       Date:  2003-02-13       Impact factor: 91.245
View more
  17 in total

1.  Do clinicians understand the size of treatment effects? A randomized survey across 8 countries.

Authors:  Bradley C Johnston; Pablo Alonso-Coello; Jan O Friedrich; Reem A Mustafa; Kari A O Tikkinen; Ignacio Neumann; Per O Vandvik; Elie A Akl; Bruno R da Costa; Neill K Adhikari; Gemma Mas Dalmau; Elise Kosunen; Jukka Mustonen; Mark W Crawford; Lehana Thabane; Gordon H Guyatt
Journal:  CMAJ       Date:  2015-10-26       Impact factor: 8.262

2.  Trial protocols: time for more than tinkering.

Authors:  James Penston
Journal:  BMJ       Date:  2005-02-19

3.  Users' guide to detecting misleading claims in research: discussion section helps redress the balance.

Authors:  S Anuradha
Journal:  BMJ       Date:  2005-01-15

4.  Users' guide to detecting misleading claims in research: misleading claims may be symptom of even more serious flaws.

Authors:  James Penston
Journal:  BMJ       Date:  2005-01-15

5.  Users' guide to detecting misleading claims in research: meta-analyses have led to misleading claims in the past.

Authors:  Peter J Horsey
Journal:  BMJ       Date:  2005-01-15

Review 6.  Waking up from the DREAM of preventing diabetes with drugs.

Authors:  Victor M Montori; William L Isley; Gordon H Guyatt
Journal:  BMJ       Date:  2007-04-28

7.  Funding a clinical trial: the perspective of a medicines funder.

Authors:  Peter Alsop; Scott Metcalfe; Jackie Evans
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

Review 8.  Incorporating considerations of resources use into grading recommendations.

Authors:  Gordon H Guyatt; Andrew D Oxman; Regina Kunz; Roman Jaeschke; Mark Helfand; Alessandro Liberati; Gunn E Vist; Holger J Schünemann
Journal:  BMJ       Date:  2008-05-24

9.  Outcomes, outcomes, every where, nor any stop to think?

Authors:  Colin P West
Journal:  J Gen Intern Med       Date:  2011-11       Impact factor: 5.128

10.  Subgroup Analysis of Trials Is Rarely Easy (SATIRE): a study protocol for a systematic review to characterize the analysis, reporting, and claim of subgroup effects in randomized trials.

Authors:  Xin Sun; Matthias Briel; Jason W Busse; Elie A Akl; John J You; Filip Mejza; Malgorzata Bala; Natalia Diaz-Granados; Dirk Bassler; Dominik Mertz; Sadeesh K Srinathan; Per Olav Vandvik; German Malaga; Mohamed Alshurafa; Philipp Dahm; Pablo Alonso-Coello; Diane M Heels-Ansdell; Neera Bhatnagar; Bradley C Johnston; Li Wang; Stephen D Walter; Douglas G Altman; Gordon H Guyatt
Journal:  Trials       Date:  2009-11-09       Impact factor: 2.279
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.